Tyra Biosciences, Inc. Common Stock (TYRA) is a publicly traded Healthcare sector company. As of November 5, 2026, TYRA trades at $20.89 with a market cap of $1.48B and a P/E ratio of -10.13. TYRA moved -3.00% today. Year to date, TYRA is -20.59%; over the trailing twelve months it is +40.86%. Its 52-week range spans $6.42 to $40.65. Analyst consensus is strong buy with an average price target of $47.40. Rallies surfaces TYRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
11 analysts cover TYRA: 0 strong buy, 11 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $47.40.
| Metric | Value |
|---|---|
| Price | $20.89 |
| Market Cap | $1.48B |
| P/E Ratio | -10.13 |
| EPS | $-2.01 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.65 |
| 52-Week Low | $6.42 |
| Volume | 542.31K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-119.95M |
| Gross Margin | 0.00% |
11 analysts cover TYRA: 0 strong buy, 11 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $47.40.